quality Home Freeze Dryer & Industrial Freeze Dryer manufacturer

Date: June 24, 2026 The global lyophilization equipment market is experiencing robust growth, with market size expected to reach $12.21 billion by 2030, according to a comprehensive market report published by The Business Research Company. The market was valued at $7.32 billion in 2025 and is projected to grow to $8.13 billion in 2026, representing a compound annual growth rate (CAGR) of 11.1%. Forecast period growth is attributed to increasing investment in biopharmaceutical and biotechnology sectors, rising demand for continuous freeze-drying technologies, expansion of contract research organizations, and adoption of automated lyophilization systems. The growth in the historic period can be traced to rising biopharmaceutical production, expansion in vaccine manufacturing, growing demand for stable drug formulations, adoption of freeze-drying in the food industry, and advancements in lab-scale lyophilization equipment. One of the key drivers is the rising prevalence of chronic diseases, which increases demand for stable biopharmaceuticals and injectable drugs that rely on freeze-drying for long-term preservation. For example, data from the UK's National Health Service shows that in 2023, 3,615,330 patients registered with primary care physicians were diagnosed with non-diabetic hyperglycemia (pre-diabetes), an 18% increase from 2022's 3,065,825 cases. Major trends shaping the market include increased demand for heat-sensitive drug preservation, growth in biopharmaceuticals and vaccines, miniaturization of laboratory freeze dryers, automation in freeze-drying processes, and expansion into food and nutraceutical applications. North America is expected to remain the largest regional market through 2025, driven by strong R&D investment and expansion in biotech and pharmaceutical manufacturing. U.S. manufacturers are expanding production capacity to maintain competitive advantages, with IMA Life North America announcing a new freeze-dryer manufacturing facility in Tonawanda, New York. The growing number of cancer patients in the U.S. — projected to reach approximately 2,041,910 new cases and 618,120 deaths by 2025, according to the American Cancer Society — further drives investment in lyophilization equipment for stable injectable drug formulations. Industrial-scale freeze-dryers hold the largest market share, driven by widespread adoption in commercial production of pharmaceuticals, biopharmaceuticals, vaccines, and freeze-dried foods. These systems offer high capacity, consistent batch quality, regulatory compliance, and advanced automation features essential for large-scale manufacturing. The increasing investments in biopharmaceutical manufacturing facilities and contract development and manufacturing organizations, coupled with rising demand for sterile injectables, continue to consolidate this segment's dominance. For international freeze-dryer buyers and industry stakeholders, these market dynamics highlight several key considerations: the growing emphasis on automated and continuous freeze-drying technologies to improve throughput and reduce cycle times; the importance of scalable equipment that can transition seamlessly from R&D to production; and the expanding application scope beyond traditional pharmaceuticals into food processing and nutraceuticals — all of which point toward sustained investment and innovation in the sector through 2030.

Date: June 15, 2026 Telstar, the Spain-headquartered pharmaceutical equipment engineering firm, presented its portfolio of laboratory and R&D freeze-drying solutions at Expoquimia 2026, held in Barcelona from June 1 to 5. Under the guiding theme "It all starts in a lab," the company demonstrated its commitment to supporting pharmaceutical and biotech companies from early research through industrial production. At Pavilion P2, Booth 94, Telstar featured its LyoQuest table-top laboratory freeze-dryer range for vials and ampoules. With a compact design and plug-and-play setup, the LyoQuest series is positioned as an ideal first freeze-drying solution for small-scale research applications. The series includes automatic, semi-automatic, and manual operating modes, allowing laboratory staff to fully control, study, and optimize process parameters. Notably, the LyoQuest Arctic model uses natural refrigerants to support long-term compliance with upcoming European regulations on fluorinated refrigerants. For customers bridging the gap between laboratory and production environments, Telstar also showcased the LyoBeta Mini freeze-dryer. This table-top solution delivers industrial-scale capabilities with a shelf temperature range from -55°C to 70°C, making it suitable for formulation development, scale-up studies, small-batch production of high-value drugs, and individualized medication. In addition to freeze-drying equipment, Telstar presented its Boreas Ultra-low Temperature Freezer range featuring upright and chest freezer options in various sizes. The new touch-screen interface with connectivity features offers laboratory staff enhanced process transparency and control, helping safeguard valuable stored products such as reagents, cells, and samples. The Boreas series achieves temperatures as low as -86°C using vacuum insulation panels and non-fluorinated natural refrigerants for future-proof compliance. Roberto Buzzi, Global Sales Manager of Telstar's R&M Division, emphasized that every new drug begins with research in a laboratory, and the quality of these first steps has a direct impact on future production success. Telstar's presence at Expoquimia reflects the sustained global demand for laboratory-scale lyophilization equipment that enables seamless scale-up to commercial production. For international buyers, Telstar's approach underscores the importance of choosing freeze-dryer suppliers that offer integrated product lines spanning R&D, pilot, and production scales — ensuring consistent performance and regulatory compliance throughout the drug development lifecycle.

Date: June 23, 2026 Yanjinpu Food Co., Ltd. (002847), a leading Chinese snack food manufacturer, has been granted a utility model patent for a konjac vacuum freeze dryer, according to data from the National Intellectual Property Administration on June 23. The patent, with authorization announcement number CN224381962U, was officially authorized on June 19, 2026. The freeze dryer features an innovative structural design centered around easy disassembly and maintenance. The cabinet body contains a drying chamber with a front-side opening, and supporting blocks with upward-extending limiting blocks are installed on the left and right side walls of the chamber. Load-bearing strips are symmetrically arranged on both sides, with insertion slots vertically aligned on the facing sides for holding materials. On the outward-facing sides, embedding slots are provided for the supporting blocks to fit into. The top wall of each embedding slot is in contact with the upper surface of the supporting block, and the insertion opening on the outward side allows the supporting block and limiting block to be horizontally inserted. A limiting slot on the top wall accommodates the limiting block, with one side wall of the limiting slot fitting closely against the corresponding side wall of the limiting block. This design enables the load-bearing strips to be installed and removed with ease, without requiring disassembly of fasteners. This significantly simplifies the cleaning and maintenance process for the equipment. Yanjinpu Food, listed on the Shenzhen Stock Exchange since February 2017, is a major player in China's snack food industry with a focus on leisure food products and deep processing of agricultural products. In 2025, the company reported revenue of 5.762 billion yuan, ranking third among 10 companies in its sector. Konjac snacks accounted for 1.737 billion yuan of total revenue, representing 30.15% of the company's overall business. This patent reflects the growing trend of specialized freeze-drying equipment design tailored to specific food categories. Konjac, a root vegetable with high water content and unique textural properties, requires precise drying conditions to maintain quality. The improved cleanability of this new design addresses a key operational pain point in food processing facilities, where hygiene standards and equipment downtime directly impact production efficiency. For international buyers, this innovation highlights how Chinese food manufacturers are investing in application-specific freeze-drying technologies that improve both product quality and operational convenience.